bucladesine has been researched along with Chronic Lung Injury in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiang, CH; Lu, HL | 1 |
Chang, ML; Chen, HI; Hsu, K; Wang, D; Wu, CP | 1 |
Barnard, J; Haynes, J; Seibert, AF; Taylor, A; Thompson, WJ; Wilborn, WH | 1 |
Adkins, WK; Barnard, JW; Haynes, J; May, S; Seibert, AF; Taylor, AE | 1 |
Bysani, GK; Gurtner, GH; Hasty, D; Hoidal, JR; Hopkins, C; Kennedy, TP; Lazar, R; Michael, JR; Sciuto, AM; Tolley, E | 1 |
5 other study(ies) available for bucladesine and Chronic Lung Injury
Article | Year |
---|---|
Combined therapy of pentastarch, dexamethasone, and dibutyryl-cAMP or beta 2-agonist attenuates ischaemia/reperfusion injury of rat lung.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Bucladesine; Cytokines; Dexamethasone; Drug Therapy, Combination; Hydroxyethyl Starch Derivatives; Lung Injury; Male; Plasma Substitutes; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Reperfusion Injury; RNA, Messenger; Vascular Resistance | 2008 |
Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP.
Topics: Adrenergic beta-Agonists; Aminophylline; Animals; Blood Pressure; Bucladesine; Capillary Permeability; Cyclic AMP; Disease Models, Animal; Humans; Lung; Lung Injury; Male; Neutrophils; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Edema; Rabbits; Respiratory Distress Syndrome; Terbutaline; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1996 |
Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP.
Topics: Animals; Bucladesine; Capillary Permeability; Colforsin; Cyclic AMP; In Vitro Techniques; Isoproterenol; Lung; Lung Injury; Male; Perfusion; Pulmonary Circulation; Rats; Reperfusion Injury | 1992 |
Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury.
Topics: Animals; Bucladesine; Capillaries; Capillary Permeability; Colforsin; Cyclic AMP; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Lung; Lung Injury; Rabbits; Reperfusion Injury; Vascular Resistance | 1992 |
Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene.
Topics: Aminophylline; Animals; Bucladesine; Isoproterenol; Lung; Lung Injury; Malondialdehyde; Phosgene; Pulmonary Edema; Rabbits; Terbutaline | 1989 |